|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US8003595B2
(en)
|
2000-03-01 |
2011-08-23 |
Cellectis |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
US7696168B2
(en)
|
2000-04-21 |
2010-04-13 |
Tufts Medical Center, Inc. |
G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
|
|
AU2001257169C1
(en)
*
|
2000-04-21 |
2011-06-16 |
Tufts Medical Center, Inc. |
G-protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
|
|
GB0313132D0
(en)
*
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
EP1653989B1
(fr)
|
2003-08-14 |
2009-07-15 |
Diatos |
Composition anti-bacterienne plus particulierement contre les bacteries gram negatif comprenent un peptide et un agent anti-bacterien avantageusement hydrophobe
|
|
EP1512696A1
(en)
*
|
2003-08-14 |
2005-03-09 |
Diatos |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
PT2332968T
(pt)
|
2003-11-05 |
2016-08-17 |
Harvard College |
Péptidos alfa-helicoidais adequados para a activação ou inibição da morte celular
|
|
US20060040882A1
(en)
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
CA2565685A1
(en)
*
|
2004-05-04 |
2005-12-15 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
CN101072566B
(zh)
*
|
2004-11-03 |
2012-05-16 |
为人技术株式会社 |
用于经皮给药的药物组合物
|
|
CA2586344C
(en)
*
|
2004-11-04 |
2013-05-28 |
New England Medical Center Hospitals, Inc. |
G protein coupled receptor agonists and antagonists and methods of use
|
|
FR2877946B1
(fr)
|
2004-11-12 |
2011-02-11 |
Commissariat Energie Atomique |
Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
|
|
CA2593956A1
(en)
|
2004-12-22 |
2006-06-29 |
Lipopeptide Ab |
Agents inhibiting the cathelin-like protein cap18/ll-37
|
|
WO2006078816A2
(en)
|
2005-01-18 |
2006-07-27 |
The Board Of Governors For Higher Education |
Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
ES2609520T3
(es)
|
2005-10-04 |
2017-04-20 |
Soligenix, Inc. |
Péptidos novedosos para tratar y prevenir trastornos relacionados con el sistema inmunitario, incluyendo el tratamiento y la prevención de infecciones modulando la inmunidad innata
|
|
JP5093100B2
(ja)
*
|
2006-03-13 |
2012-12-05 |
学校法人慶應義塾 |
インフルエンザ感染阻害ペプチド、インフルエンザウイルス感染阻害剤、リポソーム、インフルエンザ予防・治療剤
|
|
US8642559B2
(en)
*
|
2006-10-13 |
2014-02-04 |
University Of Southern California |
C-terminal domain truncation of mGluR1α by calpain and uses thereof
|
|
CN101573448B
(zh)
|
2006-12-28 |
2012-07-11 |
株式会社癌免疫研究所 |
Hla-a*1101限制的wt1肽及含有其的药物组合物
|
|
AU2008211854C1
(en)
*
|
2007-01-29 |
2014-01-23 |
Procell Therapeutics Inc. |
Novel macromolecule transduction domains and methods for identification and uses thereof
|
|
EP2118123B1
(en)
|
2007-01-31 |
2015-10-14 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
DE102007008596B4
(de)
*
|
2007-02-15 |
2010-09-02 |
Friedrich-Schiller-Universität Jena |
Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
|
|
EP3159352B1
(en)
|
2007-03-28 |
2023-08-02 |
President and Fellows of Harvard College |
Stitched polypeptides
|
|
US9078927B2
(en)
|
2007-07-06 |
2015-07-14 |
Cedars-Sinai Medical Center |
Self-assembling complex for targeting chemical agents to cells
|
|
AU2008295509A1
(en)
*
|
2007-08-29 |
2009-03-12 |
Tufts University |
Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
|
|
WO2009041902A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Loefgren Kajsa |
Prion protein derived cell penetrating peptides and their uses
|
|
TW200932260A
(en)
*
|
2007-11-28 |
2009-08-01 |
Oncotherapy Science Inc |
STAT3 epitope peptides
|
|
WO2009099677A2
(en)
|
2008-02-08 |
2009-08-13 |
Aileron Therapeutics, Inc. |
Therapeutic peptidomimetic macrocycles
|
|
EP2090584A1
(en)
|
2008-02-13 |
2009-08-19 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Identification of a novel cysteine-rich cell penetrating peptide
|
|
DE102009043743B4
(de)
|
2009-03-13 |
2016-10-13 |
Friedrich-Schiller-Universität Jena |
Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
|
|
EP2250278B1
(en)
*
|
2008-02-21 |
2023-04-05 |
Burnham Institute for Medical Research |
Methods and compositions related to peptides and proteins with c-terminal elements
|
|
GB0804496D0
(en)
|
2008-03-11 |
2008-04-16 |
Theryte Ltd |
Treating cancer
|
|
WO2009120993A2
(en)
*
|
2008-03-28 |
2009-10-01 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
|
|
JP5763525B2
(ja)
*
|
2008-05-07 |
2015-08-12 |
サーモディクス，インコーポレイティド |
粒子からの核酸複合体の送達
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EP2285970A4
(en)
*
|
2008-06-03 |
2011-10-12 |
Aileron Therapeutics Inc |
COMPOSITIONS AND METHODS FOR REINFORCING THE CELL TRANSPORT OF BIOMOLECULES
|
|
US8575305B2
(en)
|
2008-06-04 |
2013-11-05 |
Medical Research Council |
Cell penetrating peptides
|
|
ES2613866T3
(es)
|
2008-06-12 |
2017-05-26 |
Centre For Addiction And Mental Health |
Composiciones y métodos para modular la interacción y la función del receptor de dopamina D1-D2
|
|
US20110218334A1
(en)
*
|
2008-07-11 |
2011-09-08 |
Alnylam Pharmaceuticals, Inc. |
PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
|
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
US20140248296A1
(en)
*
|
2008-10-16 |
2014-09-04 |
Kathleen Cogan Farinas |
Sustained drug delivery system
|
|
WO2010053547A2
(en)
*
|
2008-11-04 |
2010-05-14 |
Anchor Therapeutics, Inc. |
Cxcr5 receptor compounds
|
|
US20110294738A1
(en)
*
|
2008-11-04 |
2011-12-01 |
Yong Ren |
Pthr1 receptor compounds
|
|
WO2010072228A1
(en)
*
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
AU2009329893A1
(en)
*
|
2008-12-23 |
2011-06-30 |
Vivoscript, Inc. |
Compositions and methods for re-programming cells without genetic modification
|
|
JP2012515172A
(ja)
|
2009-01-14 |
2012-07-05 |
エルロン・セラピューティクス・インコーポレイテッド |
ペプチド模倣大環状分子
|
|
WO2010085665A2
(en)
*
|
2009-01-23 |
2010-07-29 |
Cedars-Sinai Medical Center |
Targeted delivery system
|
|
DK2417156T3
(en)
|
2009-04-07 |
2015-03-02 |
Roche Glycart Ag |
Trivalent, bispecific antibodies
|
|
WO2010115286A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Centre For Addiction And Mental Health |
Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
|
|
US9676845B2
(en)
|
2009-06-16 |
2017-06-13 |
Hoffmann-La Roche, Inc. |
Bispecific antigen binding proteins
|
|
GB0910620D0
(en)
|
2009-06-19 |
2009-08-05 |
Immunovia Ab |
Agents and uses thereof
|
|
CN102869384B
(zh)
|
2009-06-22 |
2016-01-13 |
伯纳姆医学研究所 |
使用带有c-端元件的肽和蛋白质的方法和组合物
|
|
WO2011008260A2
(en)
|
2009-07-13 |
2011-01-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
AU2010298338A1
(en)
|
2009-09-22 |
2012-04-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9808504B2
(en)
*
|
2009-09-22 |
2017-11-07 |
Yale University |
Immunogenic epitopes as targets for universal cancer vaccines
|
|
EP3252068B1
(en)
|
2009-10-12 |
2025-07-02 |
Larry J. Smith |
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
|
|
WO2011072292A2
(en)
*
|
2009-12-11 |
2011-06-16 |
Dicerna Pharmaceuticals, Inc. |
Phase changing formulations of rna and rna derivatives
|
|
US20110159098A1
(en)
*
|
2009-12-30 |
2011-06-30 |
Surmodics, Inc. |
Stabilization and delivery of nucleic acid complexes
|
|
JP6066900B2
(ja)
|
2010-04-26 |
2017-01-25 |
エータイアー ファーマ， インコーポレイテッド |
システイニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
US8961960B2
(en)
|
2010-04-27 |
2015-02-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
|
|
JP6008837B2
(ja)
|
2010-04-28 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
アラニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
WO2011139907A2
(en)
|
2010-04-29 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
|
US8986680B2
(en)
|
2010-04-29 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
|
JP6008841B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
メチオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
US8961961B2
(en)
|
2010-05-03 |
2015-02-24 |
a Tyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
|
|
AU2011248227B2
(en)
|
2010-05-03 |
2016-12-01 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
|
EP2566499B1
(en)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
|
EP2568996B1
(en)
|
2010-05-14 |
2017-10-04 |
aTyr Pharma, Inc. |
Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
CN103096913B
(zh)
|
2010-05-27 |
2017-07-18 |
Atyr 医药公司 |
与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2800281C
(en)
|
2010-06-01 |
2021-01-12 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
|
US9540680B2
(en)
*
|
2010-06-07 |
2017-01-10 |
The Trustees Of The University Of Pennsylvania |
Transcriptome in vivo analysis
|
|
NZ704192A
(en)
*
|
2010-06-14 |
2016-05-27 |
Hoffmann La Roche |
Cell-penetrating peptides and uses therof
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
CN102947444A
(zh)
*
|
2010-06-23 |
2013-02-27 |
帷幄生物技术公司 |
用于治疗心血管疾病的非遗传修饰性重编程细胞的组合物和方法
|
|
CA2804416C
(en)
|
2010-07-12 |
2020-04-28 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
|
US8791121B2
(en)
|
2010-08-12 |
2014-07-29 |
New York University |
Oligooxopiperazines and methods of making and using them
|
|
KR102104762B1
(ko)
|
2010-08-13 |
2020-04-24 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
RU2013110876A
(ru)
*
|
2010-08-24 |
2014-09-27 |
Рош Гликарт Аг |
Активируемые биспецифические антитела
|
|
CA2807278A1
(en)
|
2010-08-24 |
2012-03-01 |
F. Hoffmann - La Roche Ag |
Bispecific antibodies comprising a disulfide stabilized - fv fragment
|
|
JP5964304B2
(ja)
|
2010-08-25 |
2016-08-03 |
エータイアー ファーマ， インコーポレイテッド |
チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
CA2807036C
(en)
|
2010-10-14 |
2018-01-16 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
US9518105B2
(en)
*
|
2010-12-08 |
2016-12-13 |
The Research Foundation For The State University Of New York |
Polypeptides derived from calcitonin receptors and methods of use
|
|
WO2012090150A2
(en)
|
2010-12-27 |
2012-07-05 |
Compugen Ltd |
New cell-penetrating peptides and uses thereof
|
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
|
CN103403025B
(zh)
|
2011-02-28 |
2016-10-12 |
弗·哈夫曼-拉罗切有限公司 |
单价抗原结合蛋白
|
|
JP5764677B2
(ja)
|
2011-02-28 |
2015-08-19 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
抗原結合タンパク質
|
|
AU2012239880B2
(en)
|
2011-04-08 |
2017-06-15 |
Tufts Medical Center, Inc. |
Pepducin design and use
|
|
US9880151B2
(en)
*
|
2011-05-23 |
2018-01-30 |
Phylogica Limited |
Method of determining, identifying or isolating cell-penetrating peptides
|
|
EP2715291A4
(en)
|
2011-05-31 |
2015-10-21 |
Airware Inc |
NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR)
|
|
WO2012174423A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of rab gtpase function
|
|
EP2537858A1
(en)
|
2011-06-20 |
2012-12-26 |
Commissariat à l'Énergie Atomique et aux Énergies Alternatives |
Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
|
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
|
WO2013030569A2
(en)
|
2011-08-30 |
2013-03-07 |
Michael John Gait |
Peptides
|
|
WO2013040015A2
(en)
*
|
2011-09-13 |
2013-03-21 |
Immunotope, Inc. |
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
US9259483B2
(en)
|
2011-11-24 |
2016-02-16 |
Positec Power Tools (Suzhou) Co Ltd |
Peptide sequence design and use thereof for peptide-mediated siRNA delivery
|
|
CN102532565B
(zh)
*
|
2011-12-19 |
2013-08-28 |
上海交通大学 |
可降解亚胺类聚阳离子及其合成方法、纳米颗粒
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
CA2864120A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
NZ627528A
(en)
|
2012-02-15 |
2016-05-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles
|
|
EP2814821B1
(en)
|
2012-02-16 |
2018-04-25 |
New York University |
Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
|
|
KR20150032265A
(ko)
*
|
2012-06-26 |
2015-03-25 |
에프. 호프만-라 로슈 아게 |
세포 침투성 펩티드 및 세포 침투성 펩티드의 식별 방법
|
|
CN104619839A
(zh)
|
2012-08-03 |
2015-05-13 |
西塞医疗中心 |
药物递送蛋白质的增强运输的突变体的分离
|
|
EP2708235A1
(en)
|
2012-09-17 |
2014-03-19 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Peptide antagonists of the vasopressin-2 receptor
|
|
EP2920197B1
(en)
|
2012-09-26 |
2021-03-17 |
President and Fellows of Harvard College |
Proline-locked stapled peptides and uses thereof
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
RU2015123315A
(ru)
|
2012-11-25 |
2017-01-10 |
Зе Реджентс Оф Зе Юниверсити Оф Калифорния |
Пептиды, стимулирующие подкожный адипогенез
|
|
ITMI20122263A1
(it)
*
|
2012-12-28 |
2014-06-29 |
Azienda Ospedaliero Universitaria Di Parma |
Nuovi peptidi cationici ciclici ad attività antimicrobica
|
|
EP2991665A4
(en)
|
2013-03-13 |
2016-11-09 |
Harvard College |
STACKED AND GRAFTED POLYPEPTIDES AND USES THEREOF
|
|
EP2784094A1
(en)
|
2013-03-28 |
2014-10-01 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
New uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination
|
|
EA201591760A1
(ru)
|
2013-03-28 |
2016-02-29 |
Коммиссариат А Л'Энержи Атомик Э О Энержи Альтернатив |
Новые уран-хелатирующие пептиды, происходящие из кальций-связывающего мотива ef-hand, пригодные для биодетекции и биодеконтаминации урана
|
|
KR20160019547A
(ko)
|
2013-06-14 |
2016-02-19 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
안정화된 폴리펩티드 인슐린 수용체 조절제
|
|
AU2014301631A1
(en)
|
2013-06-26 |
2015-08-27 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
|
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
CN105659088A
(zh)
*
|
2013-06-26 |
2016-06-08 |
菲洛吉卡有限公司 |
用于监测肽的细胞运输的方法
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EP2842566A1
(en)
|
2013-09-03 |
2015-03-04 |
Centre National De La Recherche Scientifique |
Use of arpin a new inhibitor of the arp2/3 complex for the diagnosis and treatment of diseases
|
|
RU2016115866A
(ru)
|
2013-10-11 |
2017-11-16 |
Ф. Хоффманн-Ля Рош Аг |
Мультиспецифические антитела с обменянными доменами и одинаковыми вариабельными доменами легкой цепи
|
|
JP6493216B2
(ja)
*
|
2013-11-05 |
2019-04-03 |
味の素株式会社 |
ペプチドヒドラジド、ペプチドアミド及びペプチドチオエステルの製造方法
|
|
EP3086813B9
(en)
*
|
2013-12-23 |
2023-09-27 |
Covalab |
Mtg substrates for covalent conjugation of compounds
|
|
WO2015105957A1
(en)
*
|
2014-01-08 |
2015-07-16 |
Shriners Hospitals For Children |
Pten antagonist peptides and methods of using the same
|
|
WO2015108955A2
(en)
*
|
2014-01-15 |
2015-07-23 |
The Board Of Regents Of The University Of Texas System |
Targeting of pelp1 in cancer therapy
|
|
RU2682335C2
(ru)
|
2014-01-17 |
2019-03-19 |
Сидарс-Синай Медикал Сентр |
Рецептор-направленные конструкции и их применение
|
|
EP2905031A1
(en)
|
2014-02-10 |
2015-08-12 |
B Cell Design |
A new non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection
|
|
MX2016013025A
(es)
|
2014-04-04 |
2017-04-27 |
Cedars Sinai Medical Center |
Focalizacion de cancer de mama her2+ resistente a trastuzumab con una nanoparticula dirigida de her3.
|
|
CN111620940A
(zh)
|
2014-05-21 |
2020-09-04 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
|
WO2015184125A1
(en)
|
2014-05-28 |
2015-12-03 |
The Regents Of The University Of California |
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
|
|
MX389354B
(es)
|
2014-09-24 |
2025-03-20 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y formulaciones de los mismos.
|
|
KR20170058424A
(ko)
|
2014-09-24 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티드모방 거대고리 및 이의 용도
|
|
PL3227332T3
(pl)
|
2014-12-03 |
2020-06-15 |
F. Hoffmann-La Roche Ag |
Wielospecyficzne przeciwciała
|
|
SG11201707750YA
(en)
|
2015-03-20 |
2017-10-30 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
|
PT3388075T
(pt)
|
2015-03-27 |
2023-08-18 |
Immatics Biotechnologies Gmbh |
Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
US9795624B2
(en)
|
2015-05-04 |
2017-10-24 |
Research Foundation Of The City University Of New York |
Cationic polymers as co-drugs for chemotherapeutic agents
|
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
|
ES2984663T3
(es)
|
2015-11-13 |
2024-10-30 |
Oasis Pharmaceuticals Llc |
Moduladores del receptor 2 activados por proteasa
|
|
US12050215B2
(en)
*
|
2015-11-17 |
2024-07-30 |
The Regents Of The University Of Michigan |
Macromolecular structures and uses thereof
|
|
ES2906782T3
(es)
*
|
2016-03-15 |
2022-04-20 |
Idp Discovery Pharma S L |
Péptidos con actividad antineoplásica
|
|
GB201607521D0
(en)
*
|
2016-04-29 |
2016-06-15 |
Oncolmmunity As |
Method
|
|
EP3484482A4
(en)
*
|
2016-07-15 |
2020-07-29 |
The Board of Regents of the University of Oklahoma |
ANTI-ARID3A TREATMENTS FOR INFLAMMATORY DISORDERS
|
|
GB201618432D0
(en)
*
|
2016-11-01 |
2016-12-14 |
Matn Scient Ltd |
Detection and treatment of demyelinating diseases
|
|
CN110114075B
(zh)
|
2016-11-09 |
2024-01-12 |
俄亥俄州国家创新基金会 |
含有二硫化物的细胞穿透肽及其制备和使用方法
|
|
WO2018098282A2
(en)
|
2016-11-22 |
2018-05-31 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
|
AU2017373962B2
(en)
|
2016-12-07 |
2022-03-31 |
Molecular Templates, Inc. |
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
|
|
CA3087881A1
(en)
|
2017-01-17 |
2018-07-26 |
Michael David FORREST |
Therapeutic inhibitors of the reverse mode of atp synthase
|
|
EP3360891B1
(en)
|
2017-02-14 |
2022-03-30 |
Karlsruher Institut für Technologie |
Cell penetrating peptides of human origin
|
|
EP3628047A1
(en)
|
2017-05-02 |
2020-04-01 |
Sanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
|
KR102095284B1
(ko)
*
|
2017-05-11 |
2020-04-01 |
(주)케어젠 |
메토트렉세이트와 펩타이드의 결합체
|
|
US12337000B2
(en)
|
2017-07-13 |
2025-06-24 |
Michael David FORREST |
Therapeutic modulators of the reverse mode of ATP synthase
|
|
WO2019018350A1
(en)
|
2017-07-17 |
2019-01-24 |
Keith Roizman |
TOPICAL ADMINISTRATION OF THERAPEUTIC AGENTS COMPRISING CELL PENETRATION PEPTIDES, FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES
|
|
WO2019058263A1
(en)
*
|
2017-09-19 |
2019-03-28 |
Auckland Uniservices Limited |
PEPTIDES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DYSFUNCTION OF ADIPONECTIN
|
|
US11339192B2
(en)
|
2017-10-04 |
2022-05-24 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
|
EP3720450A4
(en)
*
|
2017-12-04 |
2021-07-28 |
Heat Biologics, Inc. |
CELL-BASED VACCINE PRODUCTION
|
|
EP3784697A4
(en)
*
|
2018-04-27 |
2022-07-06 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
|
EP3790890A4
(en)
|
2018-05-09 |
2022-03-02 |
Ohio State Innovation Foundation |
CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
|
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
US12171838B2
(en)
|
2018-07-02 |
2024-12-24 |
Ohio State Innovation Foundation |
Polypeptide conjugates for intracellular delivery of nucleic acids
|
|
GB201812980D0
(en)
|
2018-08-09 |
2018-09-26 |
Univ Oxford Innovation Ltd |
Cell-penetrating peptides
|
|
GB201812972D0
(en)
|
2018-08-09 |
2018-09-26 |
Univ Oxford Innovation Ltd |
Cell-penetrating peptides
|
|
US20220048953A1
(en)
*
|
2018-09-26 |
2022-02-17 |
Kaneka Corporation |
Cell-penetrating peptide
|
|
CA3122200A1
(en)
*
|
2018-12-07 |
2020-06-11 |
Oxford University Innovation Limited |
Linkers
|
|
CN118079011A
(zh)
|
2019-02-01 |
2024-05-28 |
利兰斯坦福初级大学董事会 |
用于将核酸递送至肺部的分解性细胞穿透复合物
|
|
EP3921329A1
(en)
*
|
2019-02-04 |
2021-12-15 |
University of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
|
US12338268B2
(en)
*
|
2019-03-05 |
2025-06-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for treating protein aggregation-associated diseases
|
|
CN112279921B
(zh)
|
2019-07-11 |
2025-07-29 |
厦门大学 |
用于胞内递送分子的复合物
|
|
TWI862641B
(zh)
*
|
2019-07-22 |
2024-11-21 |
美商第一美膚公司 |
具有抗老化功效之多肽及其用途
|
|
AR119529A1
(es)
|
2019-08-02 |
2021-12-22 |
Idp Discovery Pharma S L |
Péptidos reguladores de melanocitos
|
|
CN121045395A
(zh)
*
|
2019-11-22 |
2025-12-02 |
阿尔卡梅纳干细胞治疗有限公司 |
用于去抑制re1沉默转录因子靶基因的组合物和方法
|
|
WO2021113434A1
(en)
|
2019-12-03 |
2021-06-10 |
Rodan & Fields, Llc |
Peptides and compositions for inhibiting hair growth
|
|
EP4086275A4
(en)
|
2019-12-31 |
2024-04-17 |
Xiamen University |
Multimerization delivery system for intracellular delivery of molecule
|
|
EP3906935A1
(en)
|
2020-05-06 |
2021-11-10 |
Sorbonne Universite |
Peptides for preventing or treating viral infections
|
|
CN113943778A
(zh)
*
|
2020-07-17 |
2022-01-18 |
通用电气医疗集团股份有限公司 |
用于核酸检测的分子探针及其制备方法和用途
|
|
EP4281034A1
(en)
|
2021-01-24 |
2023-11-29 |
Forrest, Michael, David |
Inhibitors of atp synthase - cosmetic and therapeutic uses
|
|
US20240182526A1
(en)
*
|
2021-03-31 |
2024-06-06 |
University Of Southern California |
Compositions and methods for modulting inflammatory and degenerative disorder
|
|
JP2024513087A
(ja)
|
2021-04-07 |
2024-03-21 |
アストラゼネカ・アクチエボラーグ |
部位特異的改変のための組成物及び方法
|
|
CN115385987B
(zh)
*
|
2021-05-19 |
2024-08-02 |
中山大学 |
一种抗鱼类神经坏死病毒的穿膜肽及其应用
|
|
KR102504190B1
(ko)
*
|
2021-06-03 |
2023-02-28 |
주식회사 레메디 |
화물분자 수송 도메인 rmmr1, 이의 변이체, 이를 포함하는 재조합 화물분자 및 이를 이용한 화물분자 수송 방법
|
|
KR102819567B1
(ko)
*
|
2021-11-24 |
2025-06-13 |
주식회사 윙스타바이오 |
아밀로이드 전구체 단백질에 대한 저해 활성을 갖는 펩타이드 및 이의 용도
|
|
KR102793149B1
(ko)
*
|
2021-11-24 |
2025-04-09 |
주식회사 윙스타바이오 |
아밀로이드 전구체 단백질에 대한 저해 활성을 갖는 펩타이드 및 이의 용도
|
|
CN114349846B
(zh)
*
|
2022-01-07 |
2023-12-15 |
天津市泌尿外科研究所 |
一种人精子膜蛋白or1d2特异性多肽与抗体的制备方法
|
|
WO2023181070A1
(en)
*
|
2022-03-23 |
2023-09-28 |
Council Of Scientific & Industrial Research |
PEPTIDE TO TREAT α-SYNUCLEIN AMYLOID BASED DISORDERS
|
|
CN116444678B
(zh)
*
|
2022-10-18 |
2024-02-02 |
百葵锐(深圳)生物科技有限公司 |
一种具有真菌抗菌抑菌性能的新型多肽
|
|
CN120641131A
(zh)
|
2022-12-01 |
2025-09-12 |
耶鲁大学 |
用于细胞内有效载荷递送的刺激反应性无痕工程化平台
|
|
WO2025172421A1
(en)
|
2024-02-14 |
2025-08-21 |
Astrazeneca Ab |
Compositions and methods for treatment of huntington's disease
|
